Colorado BioScience Association Highlights State’s Life-Saving Medical Breakthroughs for Lawmakers

Annual event brings health care innovators to share successes with legislators at the Capitol

DENVER--()--Colorado BioScience Association (CBSA) brings life science innovators to meet lawmakers and highlight Colorado’s medical innovation as part of its annual Day at the Capitol. Company leaders creating breakthrough drugs, next-generation medical and diagnostic devices and innovative digital health technologies will advocate for pro-innovation business policies. The event takes place on Wednesday, February 7 from 10:30 a.m. to 1:30 p.m. in the Old Supreme Court Chambers of the State Capitol Building.

April Giles, President & CEO of CBSA, says:

“Colorado’s health innovators create treatments and cures that enhance and save lives here in our state and around the world. Introducing our legislators to leaders developing medical breakthroughs provides a critical forum to discuss policies that promote innovation. We build strong relationships with state and federal officials to foster a business environment that supports successful companies’ growth and provides good, high-paying jobs for Coloradans.”

Highlights of the CBSA Day at the Capitol include:

  • Education on the importance of advocacy and engaging with legislators
  • Update on 2018 CBSA policy priorities
  • Introduction to Colorado State Legislators and expectations for the 2018 session
  • Remarks from Lt. Governor Donna Lynne, DrPH

Jennifer Jones, Vice President of CBSA, says:

“Improving our companies’ access to capital remains a top priority for Colorado BioScience Association. Successful programs, such as the Advanced Industries Grant Program and the Advanced Industries Investor Tax Credit provide essential funds to our early-stage companies. We want to work with the legislature to do more to boost growth companies, protect innovation and support an educated workforce.”

Since inception, the state Office of Economic Development and International Trade (OEDIT) has awarded $52 million in Advanced Industries grants to Colorado bioscience companies. The program makes a significant impact in the state, creating:

  • 67 new bioscience companies
  • 761 direct jobs
  • $521 million additional investment in bioscience

Registration for the CBSA Day at the Capitol is free for CBSA members and $50 for non-members. The event sponsors are: Fitzsimons Redevelopment Authority, Terumo BCT, PhRMA and Amgen.

Connect with CBSA: Twitter @COBioscience, Facebook and LinkedIn

About the Colorado BioScience Association

Colorado BioScience Association champions life science. We serve as the hub of Colorado’s thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. From promising young companies to established corporations and institutions, we provide opportunities for networking, education and professional development. We grow the bioscience workforce and lead business expansion policies to advance the industry in our state. CBSA represents more than 350 member organizations, including biotechnology, pharmaceutical, medical device, diagnostic, ag bio and mobile digital health companies, research and academic institutions and service providers. Learn more about us at http://www.cobioscience.com.

Contacts

Primavera Group for Colorado BioScience Association
Sheliah Reynolds
(720) 289-4739
sheliah@theprimaveragroup.com

Release Summary

CBSA brings life science innovators to meet lawmakers and highlight Colorado’s medical innovation as part of its annual Day at the Capitol.

Contacts

Primavera Group for Colorado BioScience Association
Sheliah Reynolds
(720) 289-4739
sheliah@theprimaveragroup.com